Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster
Clinical trial NCT05897190 · COMPLETED
Trial details
- NCT number
- NCT05897190
- Sponsor
- Argorna Pharmaceuticals Co., LTD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-16
- Primary completion
- 2022-06-13
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.